Ratings by KeyBanc (Paul Knight)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2026 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/17/2026 | Azenta, Inc. | AZTA | Maintain | Sector Weight (N/A) |
|
Details | ||
| 2/3/2026 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2026 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/9/2026 | AptarGroup | ATR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/29/2025 | Lifecore Biomedical | LFCR | Maintain | Sector Weight (N/A) |
|
Details | ||
| 12/18/2025 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/7/2025 | Thermo Fisher Scientific | TMO | Upgrade | Overweight (Sector Weight) |
575.24 (501.97) |
-12.74% | Details | |
| 10/24/2025 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 10/14/2025 | Exagen | XGN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2025 | Thermo Fisher Scientific | TMO | Maintain | Sector Weight (N/A) |
|
Details | ||
| 10/3/2025 | BioLife Solutions | BLFS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2025 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2025 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/10/2025 | AptarGroup | ATR | Maintain | Overweight (N/A) |
|
Details | ||
| 9/4/2025 | AptarGroup | ATR | New Coverage | Overweight (N/A) |
136.41 (132.08) |
-3.17% | Details | |
| 9/4/2025 | Lifecore Biomedical | LFCR | New Coverage | Sector Weight (N/A) |
7.46 (6.96) |
-6.7% | Details | |
| 8/28/2025 | Agilent | A | Maintain | Sector Weight (N/A) |
|
Details | ||
| 8/18/2025 | Waters Corp. | WAT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2025 | Standard BioTools Inc | LAB | Maintain | Sector Weight (N/A) |
|
Details | ||
| 8/6/2025 | CryoPort | CYRX | Upgrade | Overweight (Sector Weight) |
7.16 (8.09) |
12.99% | Details | |
| 7/30/2025 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2025 | Exagen | XGN | Upgrade | Overweight (Sector Weight) |
7.39 (3.29) |
-55.48% | Details | |
| 7/25/2025 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 6/18/2025 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2025 | Avantor Inc. | AVTR | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2025 | Waters Corp. | WAT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Exagen | XGN | Maintain | Sector Weight (N/A) |
|
Details | ||
| 5/6/2025 | Castle Biosciences | CSTL | Maintain | Overweight (N/A) |
|
Details | ||
| 4/9/2025 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 4/9/2025 | Bio-Techne Corp. | TECH | Downgrade | Sector Weight (Overweight) |
52.31 (53.89) |
3.02% | Details | |
| 4/9/2025 | Harvard Bioscience Inc. | HBIO | Downgrade | Sector Weight (Overweight) |
0.38 (0.55) |
44.74% | Details | |
| 4/1/2025 | CryoPort | CYRX | Maintain | Sector Weight (N/A) |
|
Details | ||
| 3/31/2025 | Waters Corp. | WAT | Upgrade | Overweight (Sector Weight) |
370.59 (302.54) |
-18.36% | Details | |
| 3/17/2025 | BioLife Solutions | BLFS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/5/2025 | Alpha Teknova Inc. | TKNO | Maintain | Sector Weight (N/A) |
|
Details | ||
| 2/28/2025 | Rapid Micro Biosystems Inc | RPID | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2025 | Standard BioTools Inc | LAB | Downgrade | Sector Weight (Overweight) |
1.26 (0.99) |
-21.43% | Details | |
| 2/21/2025 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2025 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2025 | Rapid Micro Biosystems Inc | RPID | New Coverage | Overweight (N/A) |
2.82 (4.12) |
46.1% | Details | |
| 2/5/2025 | Bio-Techne Corp. | TECH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2025 | Mesa Laboratories | MLAB | Maintain | Sector Weight (N/A) |
|
Details | ||
| 2/3/2025 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2025 | BioLife Solutions | BLFS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/13/2024 | BioLife Solutions | BLFS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/13/2024 | BioLife Solutions | BLFS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2024 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2024 | Exagen | XGN | Maintain | Sector Weight (N/A) |
|
Details | ||
| 11/5/2024 | Castle Biosciences | CSTL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2024 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2024 | Bio-Techne Corp. | TECH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2024 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 9/30/2024 | Avid Bioservices | CDMO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/22/2024 | Agilent | A | Maintain | Sector Weight (N/A) |
|
Details | ||
| 8/19/2024 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2024 | Harvard Bioscience Inc. | HBIO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/3/2024 | Avid Bioservices | CDMO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2024 | Castle Biosciences | CSTL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/15/2024 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2024 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2024 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2023 | Avid Bioservices | CDMO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2023 | Bio-Techne Corp. | TECH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2023 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2023 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2023 | Thermo Fisher Scientific | TMO | Downgrade | Sector Weight (Overweight) |
458.26 (575.24) |
25.53% | Details | |
| 9/27/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/30/2023 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 8/30/2023 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/21/2023 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2023 | Translate Bio | TBIO | Downgrade | Sector Weight (Overweight) |
1.35 (3.23) |
139.26% | Details | |
| 8/8/2023 | Maravai LifeScience Holdings Inc. | MRVI | Downgrade | Sector Weight (Overweight) |
11.50 (3.55) |
-69.13% | Details | |
| 7/17/2023 | CryoPort | CYRX | Downgrade | Sector Weight (Overweight) |
14.60 (8.09) |
-44.59% | Details | |
| 7/12/2023 | Standard BioTools Inc | LAB | New Coverage | Overweight (N/A) |
2.22 (1.26) |
-43.24% | Details | |
| 7/12/2023 | Alpha Teknova Inc. | TKNO | New Coverage | Sector Weight (N/A) |
2.68 (2.11) |
-21.27% | Details | |
| 5/24/2023 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/24/2023 | Agilent | A | Downgrade | Sector Weight (Overweight) |
129.09 (115.07) |
-10.86% | Details | |
| 5/10/2023 | Azenta, Inc. | AZTA | Downgrade | Sector Weight (Overweight) |
45.43 (24.30) |
-46.51% | Details | |
| 5/5/2023 | Castle Biosciences | CSTL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2023 | Avid Bioservices | CDMO | Upgrade | Overweight (Sector Weight) |
13.95 (12.49) |
-10.47% | Details | |
| 2/23/2023 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2022 | CryoPort | CYRX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2022 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 11/22/2022 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2022 | Exagen | XGN | Downgrade | Sector Weight (Overweight) |
8.30 (7.39) |
-10.96% | Details | |
| 8/5/2022 | Harvard Bioscience Inc. | HBIO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2022 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2022 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2022 | Bio-Techne Corp. | TECH | Maintain | Overweight (N/A) |
|
Details | ||
| 3/28/2022 | Codex DNA Inc. | DNAY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2022 | OncoCyte Corp | OCX | Downgrade | Sector Weight (Overweight) |
1.40 (3.20) |
128.57% | Details | |
| 3/9/2022 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2021 | Avid Bioservices | CDMO | Downgrade | Sector Weight (Overweight) |
28.18 (12.49) |
-55.68% | Details | |
| 11/17/2021 | Brooks Automation Inc. | BRKS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2021 | Exagen | XGN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2021 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/15/2021 | Bio-Techne Corp. | TECH | Upgrade | Overweight (Sector Weight) |
509.89 (53.89) |
-89.43% | Details | |
| 9/8/2021 | Avantor Inc. | AVTR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2021 | Stevanato Group S.p.A. | STVN | New Coverage | Overweight (N/A) |
20.62 (15.41) |
-25.27% | Details | |
| 7/29/2021 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2021 | Codex DNA Inc. | DNAY | New Coverage | Overweight (N/A) |
17.33 (1.30) |
-92.5% | Details | |
| 7/12/2021 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/12/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 6/30/2021 | Avid Bioservices | CDMO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/28/2021 | Berkeley Lights | BLI | Downgrade | Sector Weight (Overweight) |
48.10 (1.20) |
-97.51% | Details | |
| 5/26/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2021 | Harvard Bioscience Inc. | HBIO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2021 | Thermo Fisher Scientific | TMO | Upgrade | Overweight (Sector Weight) |
442.61 (501.97) |
13.41% | Details | |
| 2/17/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details |
